Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National Academies Press. doi: 10.17226/26554.
×
Appendix C
Open Session Agendas
Wednesday, November 18, 2020, 1:30 – 4:00 p.m. (ET)
Web Conference
Open Session Agenda
| 1:30 – 1:45 | Welcome and introductions |
| Bernard Rosof, M.D., Committee Chair, and Committee | |
| 1:45 – 2:00 | Sponsor charge to the committee |
| Ellen Goldmuntz, M.D., Ph.D., Section Chief, Rheumatologic Autoimmune Disease Section, National Institute of Allergy and Infectious Diseases (NIAID), NIH | |
| 2:00 – 2:10 | Study background |
| Alex Keenan, Clerk, Subcommittee on Labor, Health and Human Services, Education and Related Agencies, Senate Committee on Appropriations (Minority Staff) |
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National Academies Press. doi: 10.17226/26554.
×
| 2:10 – 2:25 | Overview of NIH Institutes and Centers and funding structure |
| James McNamara, M.D., Section Chief, Autoimmunity and Mucosal Immunology Branch, Division of Allergy, Immunology and Transplantation, NIAID, NIH | |
| 2:25 – 3:05 | State of autoimmune diseases in the U.S. |
| Virginia Ladd, Founder, Past President Emerita, Advisor to the President, American Autoimmune Related Diseases Association | |
| 3:05 – 3:45 | Autoimmune disease research in the U.S. |
| Jane Buckner, M.D., President, Benaroya Research Institute at Virginia Mason | |
| 3:45 – 4:00 | Q & A |
| 4:00 | Adjourn |
Open Session
February 1 – 2, 2021
Full Schedule in Eastern Time
Web Conference
Meeting Agenda1
February 1, 2021, 1:15 – 4:40p
OPEN SESSION
| 1:15 – 1:30 | Open Session Begins |
| 1:30 – 1:45 | Welcome and introductions |
| Bernard Rosof, M.D., Committee Chair and Committee | |
| 1:45 – 2:10 | NIH Extramural Grant Review Process – Center for Scientific Review (CSR) |
| Deborah Hodge, Ph.D., Scientific Review Officer, Division of Physiological and Pathological Sciences, CSR, NIH |
___________________
1 All presentations and slides for open sessions can be found at https://www.nationalacademies.org/our-work/assessment-of-nih-research-on-autoimmune-diseases#sectionPastEvents.
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National Academies Press. doi: 10.17226/26554.
×
| 2:10 – 2:35 | Advancing Women’s Health Research at NIH |
| Lisa Begg, Dr.P.H., R.N., Senior Research Program Officer, Office of Research on Women’s Health (ORWH), NIH | |
| 2:35 – 2:45 | Break |
| 2:45 – 2:55 | Panel Discussion: NIH Autoimmune Research across ICs |
| Introductions – Committee Moderator | |
| 2:55 – 3:10 | James McNamara, M.D., Section Chief, Autoimmunity and Mucosal Immunology Branch, Division of Allergy, Immunology and Transplantation, NIAID, NIH |
| 3:10 – 3:25 | Marie Mancini, Ph.D., Program Director, Systemic Autoimmune Disease Biology Program, National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS), NIH |
| 3:25 – 3:40 | Ursula Utz, Ph.D., Program Director, Neuroimmunology, Autoimmunity, Neurovirology, Multiple Sclerosis, National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| 3:40 – 3:55 | Ruth Kirby, Clinical Trials Specialist, National Heart, Lung, and Blood Institute (NHLBI), NIH |
| 3:55 – 4:30 | Discussion |
| 4:30 | Adjourn |
February 2, 2021, 1:00 – 3:15p
OPEN SESSION
| 1:00 – 1:05 | Welcome and Introductions |
| Bernard Rosof, M.D., Committee Chair | |
| 1:05 – 1:30 | Advances and Opportunities in Multiple Sclerosis |
| Nicholas LaRocca, Ph.D., Consultant, National Multiple Sclerosis Society (NMSS) |
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National Academies Press. doi: 10.17226/26554.
×
| 1:30 – 1:55 | Advances and Opportunities in Autoimmune Arthritis |
| Emily von Scheven, M.D., M.A.S., Chief of Rheumatology, UCSF Benioff Children’s Hospital | |
| Mary K. Crow, M.D., Director, Autoimmunity and Inflammation Research Program; Co-Director, Mary Kirkland Center for Lupus Research at the HSS Research Institute | |
| 1:55 – 2:20 | Advances and Opportunities in Type 1 Diabetes |
| Sanjoy Dutta, Ph.D., Vice President for Research, Juvenile Diabetes Research Foundation | |
| 2:20 – 2:45 | Advances and Opportunities in Inflammatory Bowel Disease |
| Caren Heller, M.D., M.B.A., Chief Scientific Officer, Crohn’s & Colitis Foundation | |
| 2:45 – 3:15 | Discussions |
| 3:15 | Adjourn |
March 4 – 5, 2021
Public Session
Web Conference
Meeting Agenda
Thursday, March 4, 2021, 1:30 – 5:30 pm (EST)
| 1:30 | Public Session Begins |
| 1:30 – 1:45 | Welcome and introductions |
| Bernard Rosof, M.D., Committee Chair and Committee |
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National Academies Press. doi: 10.17226/26554.
×
| NIH Intramural Research for Autoimmune Diseases | |
| 1:45 – 2:10 | Daniel Kastner, M.D., Ph.D., Scientific Director, Division of Intramural Research, NHGRI, NIH |
| 2:10 – 2:35 | Karyl S. Barron, M.D., Deputy Director, Division of Intramural Research, NIAID, NIH |
| 2:35 – 3:00 | Lisa G. Rider, M.D., Acting Head, Environmental Autoimmunity Group, Clinical Research Branch, NIEHS, NIH |
| 3:00 – 3:25 | John O’Shea, Ph.D., Scientific Director and Director of Intramural Research Program, NIAMS, NIH |
| 3:25 – 3:40 | Break |
| NIH Extramural Research for Autoimmune Diseases Across ICs | |
| 3:40 – 4:05 | Lisa Spain, Ph.D., Program Director, Division of Diabetes, Endocrinology, and Metabolic Diseases, NIDDK, NIH |
| 4:05 – 4:30 | Michael C. Humble, Ph.D., Program Administrator, Genes, Environment and Health Branch, Division of Extramural Research and Training, NIEHS, NIH |
| 4:30 – 4:55 | Nishadi Rajapakse, Ph.D., M.H.S., Program Director, Transdisciplinary Collaborative Centers on Precision Medicine, |
| Centers of Excellence on Environmental Health Disparities, Division of Scientific Programs, NIMHD, NIH | |
| 4:55 – 5:30 | Discussion |
| 5:30 | Adjourn |
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Enhancing NIH Research on Autoimmune Disease. Washington, DC: The National Academies Press. doi: 10.17226/26554.
×
Friday, March 5, 2021, 1:00 – 3:15 pm (EST)
| 1:00 | Public Session Begins |
| 1:00 – 1:05 | Welcome and Introductions |
| Bernard Rosof, M.D., Committee Chair | |
| 1:05 – 1:30 | Advances and Opportunities in Lupus |
| Judith A. James, M.D, Ph.D, Vice President of Clinical Affairs, | |
| Member & Chair, Arthritis & Clinical Immunology, Oklahoma Medical Research Foundation; | |
| Associate Vice Provost for Clinical and Translational Science, | |
| Professor of Medicine, Professor of Pathology, Oklahoma University Health Sciences Center | |
| 1:30 -1:55 | Advances and Opportunities in Dermatological Autoimmune Diseases |
| Victoria P. Werth, M.D., Professor of Dermatology at the Hospital of the University of Pennsylvania and the Veteran’s Administration (V.A.) Medical Center; Chief, Dermatology, Philadelphia V.A. Hospital | |
| 1:55 – 2:20 | Advances and Opportunities in Autoimmune Thyroid Diseases |
| Yaron Tomer M.D., Anita and Jack Saltz Chair in Diabetes Research | |
| Professor and Chair, Department of Medicine | |
| Albert Einstein College of Medicine, Montefiore Medical Center | |
| 2:20 – 2:45 | Advances and Opportunities in Primary Biliary Cholangitis |
| Mark Pedersen, M.D., Assistant Professor of Medicine, Division of Digestive and Liver Disease, University of Texas Southwestern Medical Center | |
| 2:45 – 3:15 | Discussion |
| 3:15 | Adjourn |
